Main public logs

Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

14:18, 4 July 2024 JDoerfler talk contribs created page Bairati et al. (2005): A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients (Created page with "{{Reference |Reference=Publication: A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specificat...")
14:17, 4 July 2024 JDoerfler talk contribs created page Publication: A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients (Created page with "{{Publication |Title=A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients |Topic=Vitamin E |Author=Bairati, I; Meyer, F; Gélinas, M; Fortin, A; Nabid, A; Brochet, F; Mercier, J. P; Têtu, B; Harel, F; Mâsse, B; Vigneault, É; Vass, S; del Vecchio, P; Roy, J |Year=2005 |Journal=Journal of the National Cancer Institute |DOI=https://10.1093/jnci/dji095 |Authors Abstract=Background: Although low dietary intakes of an...")
14:00, 4 July 2024 CHoppe talk contribs created page Shapiro et al. (2016): Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) (Created page with "{{Reference |Reference=Publication: Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) }} {{Study Note}} =Brief summary= This study investigated the efficacy of high-dose vitamin D3 with regard to muscular symptoms associated with aromatase inhibitors. No significant differences were found between the arms that received high-dose vitamin D and the control arm that only received standard vitamin D therapy....")
13:56, 4 July 2024 CHoppe talk contribs created page Publication: Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) (Created page with "{{Publication |Title=Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) |Topic=Vitamin D |Author=Shapiro, AC; Adlis, SA; Robien, K; Kirstein, MN; Liang, S; Richter, SA; Lerner, RE |Year=2016 |Journal=Breast cancer Research and Treatment |DOI=10.1007/s10549-016-3710-6 |Authors Abstract=Purpose: To evaluate the efficacy and safety of vitamin D3 at 4,000 IU/day as a treatment option for aromatase inhibitor as...")
13:37, 4 July 2024 JDoerfler talk contribs created page Azizi et al. (2015): Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis (Created page with "{{Reference |Reference=Publication: Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=...")
13:37, 4 July 2024 JDoerfler talk contribs created page Publication: Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis (Created page with "{{Publication |Title=Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis |Topic=Vitamin E |Author=Azizi, A; Alirezaei, S; Pedram, P; Mafi, AR |Year=2015 |Journal=Reports of Radiotherapy and Oncology |DOI=https://0.5812/rro.2(1)2015.796 |Authors Abstract=Background: There is still no consensus regarding the optimum treatment of chemotherapy-induced oral mucositis, and its management is still mainly supportive. Vitamin E has been sh...")
13:09, 4 July 2024 JDoerfler talk contribs created page Argyriou et al. (2006): Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation (Created page with "{{Reference |Reference=Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |E...")
13:08, 4 July 2024 JDoerfler talk contribs created page Publication: Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation (Created page with "{{Publication |Title=Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Journal of Pain and Symptom Management |DOI=https://10.1016/j.jpainsymman.2006.03.013 |Authors Abstract=A randomized, controlled trial was performed to assess the efficacy and safety of vitamin E supplement...")
11:54, 4 July 2024 CHoppe talk contribs created page Scher et al. (2011): Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer (Created page with "{{Reference |Reference=Publication: Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer }} {{Study Note}} =Brief summary= In this study, prostate cancer patients were examined, with one half receiving docetaxel and a vitamin D analog (arm A) and the other half docetaxel and prednisone (arm B). Patients in arm A lived significantly shorter than those in arm B....")
11:52, 4 July 2024 CHoppe talk contribs created page Publication: Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer (Created page with "{{Publication |Title=Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer |Topic=Vitamin D |Author=Scher, H; Jia, X; Chi, K; Wit, R de; Berry, WR; Albers, P; Henick, B; Waterhouse, D; Ruether, DJ; Rosen, PJ; Meluch, AA; Nordquist, LT; Venner, PM; Heidenreich, A; Chu, L; Heller, G |Year=2011 |Journal=Journal of Clinical Oncology |DOI=10.1200/JCO.2010.32.8815 |A...")
11:33, 4 July 2024 DDeel talk contribs created page Publication: A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients (Created page with "{{Publication |Title=A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients |Topic=Vitamin A (beta-carotene), Vitamin E |Author=Bairati, I; Meyer, F; Gélinas, M; Fortin, A; Nabid, A; Brochet, F; Mercier, J; Têtu, B; Harel, F; Mâsse, B; Vigneault, É; Vass, S; del Vecchio, P; Roy, J |Year=2005 |Journal=Journal of the National Cancer Institute |DOI=https://doi.org/10.1093/jnci/dji095 |Authors Abstract=Background: Al...")
11:30, 4 July 2024 JDoerfler talk contribs created page Argyriou et al. (2006): A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results (Created page with "{{Reference |Reference=? }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of data collection=? |LoE=? |Outcome timeline=? }} =Characteristics of participants= {{Cha...")
11:29, 4 July 2024 JDoerfler talk contribs deleted page Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results (content was: "{{Publication |Title=A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Supportive care in cancer |DOI...", and the only contributor was "JDoerfler" (talk))
11:29, 4 July 2024 JDoerfler talk contribs created page Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results (Created page with "{{Publication |Title=A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Supportive care in cancer |DOI=https://10.1007/s00520-006-0072-3 |Authors Abstract=Aim: A randomized, open-label with blind assessme...")
11:26, 4 July 2024 JDoerfler talk contribs created page Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results (Created page with "{{Publication |Title=A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Supportive care in cancer |DOI=https://10.1007/s00520-006-0072-3 |Authors Abstract=Aim: A randomized, open-label with blind assessme...")
10:34, 4 July 2024 CHoppe talk contribs created page Rastelli et al. (2011): Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial (Created page with "{{Reference |Reference=Publication: Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial }} {{Study Note}} =Brief summary= In this study, breast cancer patients who had already received aromatase inhibitor therapy for at least 8 weeks before the start of the study were examined with regard to typical side effects (musculoskeletal disorders, AIMSS) of this treatment. One arm received vit...")
10:30, 4 July 2024 CHoppe talk contribs created page Publication: Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial (Created page with "{{Publication |Title=Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial |Topic=Vitamin D |Author=Rastelli, AL; Taylor, ME; Gao, F; Armamento-Villareal, R; Jamalabadi-Majidi, S; Napoli, N; Ellis, MJ |Year=2011 |Journal=Breast Cancer Research and Treatment. |DOI=10.1007/s10549-011-1644-6 |Authors Abstract=Abstract A double-blind placebo-controlled randomized phase II trial was performed...")
09:33, 4 July 2024 Cotto talk contribs changed group membership for Lbordihn from (none) to interface administrator, bureaucrat, suppressor, curator (Semantic MediaWiki) and editor (Semantic MediaWiki)
08:57, 4 July 2024 EProba talk contribs created page Stendell-Hollis et al. (2010): Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors (Created page with "{{Reference |Reference=Publication: Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors }} {{Study Note |Study Note=? }} =Brief summary= In this study, 54 overweight patients who had survived breast cancer were divided into one of two groups. One group drank 960ml of caffeine-free green tea (including 128.84mg EGCG) daily for 6 months and the control group drank herbal tea. Neither the participants...")
08:15, 4 July 2024 EProba talk contribs created page Stendell-Hollis, N. R.; Thomson, C. A.; Thompson, P. A.; Bea, J. W.; Cussler, E. C.; Hakim, I. A. (Created page with "{{Author}}")
08:15, 4 July 2024 EProba talk contribs created page Publication: Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors (Created page with "{{Publication |Title=Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors |Topic=Green tea (EGCG) |Author=Stendell-Hollis, N. R.; Thomson, C. A.; Thompson, P. A.; Bea, J. W.; Cussler, E. C.; Hakim, I. A. |Year=2010 |Journal=Journal of human nutrition and dietetics: the official journal of the British Dietetic Association |DOI=https://doi.org/10.1111/j.1365-277X.2010.01078.x |Authors Abstract=Backgrou...")
07:33, 4 July 2024 CHoppe talk contribs created page Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients (Created page with "{{Reference |Reference=Publication: Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients }} {{Study Note}} =Brief summary= In this study, the effectiveness of a vitamin D ointment was investigated with regard to typical adverse skin reactions associated with radiotherapy treatment. Breast cancer patients were given a vitamin D ointment on one side of the treated breast and a normal control ointment on the other half. There were no significa...")
07:31, 4 July 2024 CHoppe talk contribs created page Publication: Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients (Created page with "{{Publication |Title=Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients |Topic=Vitamin D |Author=Nasser, NJ; Fenig, S; Ravid, A; Nouriel, A; Ozery, N; Gardyn, S; Koren, R; Fenig, E |Year=2017 |Journal=NPJ Breast Cancer |DOI=10.1038/s41523-017-0006-x |Authors Abstract=Radiation dermatitis occurs frequently during adjuvant radiation therapy for breast cancer. Prevention of radiation dermatitis by applying various creams and ointments has a...")
12:02, 3 July 2024 Cotto talk contribs created page TestPublication (Created page with "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Journal of Radiation Oncology – Biology – Physics |DOI=https://doi.org/10.1016/j.ijrobp.20...")
11:59, 3 July 2024 Cotto talk contribs created page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Journal of Radiation Oncology – Biology – Physics |DOI=https://doi.org/10.1016/j.ijrobp.20...")
11:54, 3 July 2024 Cotto talk contribs deleted page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (content was: "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Jour...", and the only contributor was "Cotto" (talk))
11:47, 3 July 2024 Cotto talk contribs created page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Journal of Radiation Oncology – Biology – Physics |DOI=https://doi.org/10.1016/j.ijrobp.20...")
11:46, 3 July 2024 Cotto talk contribs deleted page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (content was: "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Journal of Radiation Oncology – Biology – Physics |DOI=https://doi.org/10.1016/j.ijrobp.2009.08.0...")
11:46, 3 July 2024 Cotto talk contribs created page Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology }} =Brief summary= This study included 81 patients with uterine or cervical cancer. They were randomly divided into two arms and received either 500µg selenium in addition to radiotherapy or no additional preparations. All participants had a selenium deficiency at the beginning of the study. After about 7 weeks and thus the...")
11:45, 3 July 2024 Cotto talk contribs deleted page Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (content was: "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology }} =Brief summary= This study included 81 patients with uterine or cervical cancer. They were randomly divided into two arms and received either 500µg selenium in addition to radiotherapy or no additional preparations. All participants...", and the only contributor was "Cotto" (talk))
11:45, 3 July 2024 Cotto talk contribs created page Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology }} =Brief summary= This study included 81 patients with uterine or cervical cancer. They were randomly divided into two arms and received either 500µg selenium in addition to radiotherapy or no additional preparations. All participants had a selenium deficiency at the beginning of the study. After about 7 weeks and thus the...")
11:44, 3 July 2024 Cotto talk contribs deleted page Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (content was: "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology }} =Brief summary= This study included 81 patients with uterine or cervical cancer. They were randomly divided into two arms and received either 500µg selenium in addition to radiotherapy or no additional preparations. All participants had a selenium deficiency at the beginning of the study. After about 7 weeks and thus the end of...")
11:29, 3 July 2024 Cotto talk contribs created page Template:Study Note (Created page with "<noinclude> {{#template_params:}} </noinclude><includeonly>{| class="wikitable" |- ! |{{#ask:[[ALlows value::{{SUBJECTPAGENAME}}]]|format=list}} |} </includeonly>")
11:24, 3 July 2024 Cotto talk contribs created page Property:Study Note (Created a property of type Text)
11:15, 3 July 2024 Cotto talk contribs created page Template:Additional Notes (Created page with "<noinclude> {{#template_params:}} </noinclude><includeonly>{| class="wikitable" |- ! |{{#ask:[[ALlows value::{{SUBJECTPAGENAME}}]]|format=list}} |} </includeonly>")
11:13, 3 July 2024 Cotto talk contribs created page Property:Additional Notes (Created a property of type Text)
07:37, 3 July 2024 DDeel talk contribs created page Van Zandwijk et al. (2000): EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer (Created page with "{{Reference |Reference=Publication: EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer }} =Brief summary= In this study, 4 groups of head and neck tumor or lung cancer patients after radiotherapy and/or tumor surgery were compared with each other. One group received vitamin A, one group received N-acetylcysteine (NAC, a chemical agent with mucolytic properties), one group received vitamin A and NAC and a co...")
07:35, 3 July 2024 DDeel talk contribs created page Publication: EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer (Created page with "{{Publication |Title=EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer |Topic=Vitamin A (beta-carotene) |Author=van Zandwijk, N; Dalesio, O; Pastorino, U; de Vries, N; van Tinteren, H |Year=2000 |Journal=Journal of the National Cancer Institute |DOI=https://doi.org/10.1093/jnci/92.12.977 |Authors Abstract=Background: Preclinical evidence suggests that retinoids and antioxidants may prevent or delay the occ...")
11:45, 2 July 2024 CHoppe talk contribs created page Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial (Created page with "{{Reference |Reference=Publication: Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis...")
11:44, 2 July 2024 CHoppe talk contribs created page Publication: Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial (Created page with "{{Publication |Title=Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial |Topic=Vitamin D |Author=Khan, Q; Kimler, BF; Reddy, PS; Sharma, P; Klemp, JR; Nydegger, JL; Yeh, H-W; Fabian, CJ |Year=2017 |Journal=Breast Cancer Research and treatment |DOI=10.1007/s10549-017-4429-8 |Authors Abstract=Purpose: Aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) frequen...")
10:33, 2 July 2024 CHoppe talk contribs created page Jacot et al. (2016): Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study (Created page with "{{Reference |Reference=Publication: Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study }} =Brief summary= In this study, two groups of breast cancer patients with vitamin D deficiency were examined who either received high doses of vitamin D (arm A) or standard vitamin D therapy (arm B) 7 to 12 months after the start of their chemotherapy. After 6 months, a higher r...")
10:32, 2 July 2024 CHoppe talk contribs created page Publication: Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study (Created page with "{{Publication |Title=Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study |Topic=Vitamin D |Author=Jacot, W; Firmin, N; Roca, L; Topart, D; Gallet, S; Durigova, A; Mirr, S; Abach, L; Pouderoux, S; D'Hondt, V; Bleuse, J; Lamy, P; Romieu, G |Year=2016 |Journal=Annals of Oncology |DOI=https://doi.org/10.1093/annonc/mdw145 |Authors Abstract=Background: A minority of early...")
07:00, 2 July 2024 CHoppe talk contribs created page Beer et al. (2007): Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators (Created page with "{{Reference |Reference=Publication: Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators }} =Brief summary= Beer (2007). This study also investigated the effectiveness of vitamin D in combination with docetaxel (a chemotherapeutic agent) in prostate cancer patients. One group received docetaxel and vitamin D and the other group docetaxel...")
06:50, 2 July 2024 CHoppe talk contribs created page Publication: Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators (Created page with "{{Publication |Title=Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators |Topic=Vitamin D |Author=Beer, T; Ryan, CW; Venner, PM; Petrylak, DP; Chatta, GS; Ruether, JD; Redfern, CH; Fehrenbacher, L; Saleh, MN; Waterhouse, DM; Carducci, MA; Vicario, D; Dreicer, R; Higano, CS; Ahmann, FR; Chi, KN; Henner, WD; Arroyo, A; Clow, FW; ASCENT Inv...")
06:40, 2 July 2024 User account Lbordihn talk contribs was created by Cotto talk contribs and password was sent by email
06:34, 2 July 2024 User account Testuser talk contribs was created by Cotto talk contribs and password was sent by email
13:16, 1 July 2024 JDoerfler talk contribs deleted page Pubclivation: TItel STudie (content was: "{{Publication |Title=5 |Topic=Zeolites |Author=re |Year=34 |Journal=rh |Authors Abstract=? }}", and the only contributor was "JDoerfler" (talk))
13:16, 1 July 2024 JDoerfler talk contribs deleted page Syrh (content was: "{{Reference |Reference=Pubclivation: TItel STudie }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Coun...", and the only contributor was "JDoerfler" (talk))
13:08, 1 July 2024 JDoerfler talk contribs created page Pubclivation: TItel STudie (Created page with "{{Publication |Title=5 |Topic=Zeolites |Author=re |Year=34 |Journal=rh |Authors Abstract=? }}")
13:04, 1 July 2024 JDoerfler talk contribs created page Syrh (Created page with "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of data collection=? |LoE=? |Outcome timeline=? }} =Characteristics of participants= {{Characteristics of participants |...")